AI brief of an SEC Form 8-K · Climb Global Solutions, Inc. (CLMB)

Climb Global Solutions completes €16.0 million purchase of France's NeoVAD

Neutral Impact 3 of 5 m&a Written later

Climb Global Solutions, Inc. completed the purchase of 100% of NeoVAD, a France-based value-added IT distributor, under an agreement signed October 21, 2026, for approximately €16.0 million ($18.0 million), subject to adjustments. Management expects the deal to be accretive to earnings per share and adjusted EBITDA, and NeoVAD reported 2025 EBITDA of approximately €2.2 million ($2.5 million) based on its internal financial statements.

Key points

  • Sale and Purchase Agreement dated October 21, 2026; Climb acquired all issued and outstanding shares of NeoVAD for approximately €16.0 million ($18.0 million), subject to certain adjustments.
  • NeoVAD's EBITDA for fiscal 2025 was approximately €2.2 million ($2.5 million), up 487% from approximately €378,000 ($427,000) in the prior fiscal year; the company notes these figures are unaudited management figures and may not be comparab
  • NeoVAD has approximately 300 active resellers and relationships with vendors including Cato Networks, DataCore and Netwrix.
  • CEO Dale Foster said Climb expects the acquisition to be accretive to earnings and adjusted EBITDA; the filing gives no revised Climb guidance.

The filing

CompanyClimb Global Solutions, Inc. (CLMB)
Form8-K, current report
Filed with the SECOct 22, 2026, 8:59 AM ET
Accession number0001437749-26-033185

Items reported: 1.01 Material Definitive Agreement7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.